DNA vaccine-mediated immune responses in Coxsackie virus B3-infected mice

Antiviral Research

Volumn 49, Issue 1, 2001, Pages 49-54

  Henke, Andreas ^a   Zell, Roland ^a   Stelzner, Axel ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Coxsackie virus; DNA vaccine; Immune response

Indexed keywords

CAPSID PROTEIN; CYTOKINE; DNA VACCINE; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; COXSACKIE VIRUS B3; CYTOTOXIC T LYMPHOCYTE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSTIMULATION; INFECTION PREVENTION; MALE; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS LOAD;

ANIMALS; ANTIBODIES, VIRAL; BODY WEIGHT; CAPSID; COXSACKIEVIRUS INFECTIONS; CYTOKINES; DISEASE-FREE SURVIVAL; ENTEROVIRUS; GENETIC VECTORS; HEART; MALE; MICE; MICE, INBRED BALB C; MYOCARDIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VACCINES, DNA; VIRAL LOAD;

COXSACKIEVIRUS; MIRIDAE;

EID: 0035122776     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(00)00132-7     Document Type: Article

References (24)

1. HIV-1 DNA vaccines and chemokines
2. Enteroviral infection of mice with severe combined immunodeficiency. Evidence for direct viral pathogenesis of myocardial injury
3. High yield production of an inactivated Coxsackie B3 adjuvant vaccine with protective effect against experimental myocarditis
4. Myocardial enzyme activities in plasma after whole-heart irradiation in rats
5. Coxsackievirus B3-induced myocarditis: Perforin exacerbates disease, but plays no detectable role in virus clearance
6. Identification of serotype-specific and non-serotype-specific B-cell epitopes of Coxsackie B virus using synthetic peptides
7. The role of CD8+ T lymphocytes in Coxsackie virus B3-induced myocarditis
8. Protection of mice against lethal Coxsackie virus B3 infection by using DNA immunization
9. Recombinant fusion protein and DNA vaccines against foot and mouth disease virus infection in guinea pig and swine
10. Modulation of cytokine expression by CD4+ T cells during Coxsackie virus B3 infections of BALB/c mice initiated by cells expressing the gamma delta + T-cell receptor
11. Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with Coxsackie virus group B type 3
12. Cloning and expression of the VP1 major capsid protein of diabetogenic encephalomyocarditis (EMC) virus and prevention of EMC virus-induced diabetes by immunization with the recombinant VP1 protein
13. Vaccination and protection from a lethal viral infection: Identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope
14. The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes
15. The role of B lymphocytes in Coxsackie virus B3 infection
16. Molecular packing in virus crystals: Geometry, chemistry, and biology
17. Susceptibility to myocarditis is dependent on the response of alphabeta T lymphocytes to Coxsackie viral infection
18. Enhanced protection against viral infection by co-administration of plasmid DNA coding for viral antigen and cytokines in mice
19. Evaluation of novel human immunodeficiency virus type 1 gag DNA vaccines for protein expression in mammalian cells and induction of immune responses
20. Myocarditis and pericarditis
21. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice
22. Occurrence of Coxsackie virus hepatitis in baby rabbits and protection by a formalin-inactivated polyvalent vaccine
23. Low-level expression of a mutant Coxsackie viral cDNA induces a myocytopathic effect in culture: An approach to the study of enteroviral persistence in cardiac myocytes
24. DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection